John Nicols has been the CEO of Codexis, Inc. (NASDAQ:CDXS) since 2012. First, this article will compare CEO...
Credit Suisse AG cut its holdings in shares of Codexis, Inc. (NASDAQ:CDXS) by 15.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Co
Codexis, Inc. (NASDAQ:CDXS) Director Thomas R. Baruch sold 7,500 shares of Codexis stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $10.88, for a
Envestnet Asset Management Inc. boosted its holdings in shares of Codexis, Inc. (NASDAQ:CDXS) by 18.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,
Codexis, Inc. (NASDAQ:CDXS) was the target of a significant growth in short interest in March. As of March 13th, there was short interest totalling 5,621,600 shares, a growth of 5.5% from the February

Codexis (NASDAQ:CDXS) Stock Price Up 5.7%

07:12am, Tuesday, 31'st Mar 2020
Shares of Codexis, Inc. (NASDAQ:CDXS) rose 5.7% during mid-day trading on Monday . The company traded as high as $10.95 and last traded at $10.90, approximately 292,630 shares changed hands during mid
Codexis, Inc. (NASDAQ:CDXS) Director Dennis P. Wolf sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $10.
Equities research analysts expect that Codexis, Inc. (NASDAQ:CDXS) will report $14.23 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estim
In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Codexis (CDXS), with a price target of $22.50. The
Bank of Montreal Can grew its position in Codexis, Inc. (NASDAQ:CDXS) by 34.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,987 shar
Codexis (NASDAQ:CDXS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Accor

Codexis (NASDAQ:CDXS) Trading 11% Higher

09:50am, Tuesday, 24'th Mar 2020
Codexis, Inc. (NASDAQ:CDXS) shares traded up 11% on Monday . The stock traded as high as $10.22 and last traded at $9.97, 663,840 shares were traded during mid-day trading. An increase of 54% from the
Codexis (NASDAQ:CDXS) has signed a strategic collaboration and license agreement with Takeda Pharmaceutical (OTCPK:TKPHF) for the research and development of novel gene therapies for certain disease i
Codexis signs strategic collaboration, license agreement with Takeda CDXS TAK
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE